Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 14,405.2 | 13,349.1 | 11,850.4 | 9,359.3 |
yoy growth (%) | 7.91 | 12.64 | 26.61 | -3.7 |
Raw materials | -5,045.9 | -4,123 | -3,573.8 | -2,631 |
As % of sales | 35.02 | 30.88 | 30.15 | 28.11 |
Employee costs | -2,434.6 | -2,270.1 | -2,030.2 | -1,843 |
As % of sales | 16.9 | 17 | 17.13 | 19.69 |
Other costs | -4,330.6 | -3,819.2 | -3,376.8 | -3,555.4 |
As % of sales (Other Cost) | 30.06 | 28.61 | 28.49 | 37.98 |
Operating profit | 2,594.1 | 3,136.8 | 2,869.6 | 1,329.9 |
OPM | 18 | 23.49 | 24.21 | 14.2 |
Depreciation | -814.3 | -835 | -789.2 | -774.1 |
Interest expense | -38 | -46.7 | -47.8 | -62.8 |
Other income | 482 | 801.1 | 743.2 | 204 |
Profit before tax | 2,223.8 | 3,056.2 | 2,775.8 | 696.99 |
Taxes | -600.6 | -869.8 | 161.9 | -130.1 |
Tax rate | -27 | -28.46 | 5.83 | -18.66 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 1,623.2 | 2,186.4 | 2,937.7 | 566.89 |
Exceptional items | 0 | 0 | 0 | 0 |
Net profit | 1,623.2 | 2,186.4 | 2,937.7 | 566.9 |
yoy growth (%) | -25.75 | -25.57 | 418.2 | -59.04 |
NPM | 11.26 | 16.37 | 24.78 | 6.05 |
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.
Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.
Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.
Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.
EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.
Here are some of the stocks that may see significant price movement today: Mazagon Dock Shipbuilders, Krsnaa Diagnostics, Dr Reddy's, etc.
The experiment also had a favourable safety profile, with no serious adverse effects such as Cytokine Release Syndrome (CRS) or neurotoxicity reported.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.